Atlas Trials

Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453

Clinical trial NCT02845037 · COMPLETED

Trial details

NCT number
NCT02845037
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionChronic Heart Failure
Start date
2007-05-01
Primary completion
2007-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.